Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 170 results

Search term: MF = 'C_{26}H_{32}ClN_{3}O_{2}S'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
2886538
InChI=1/C26H32ClN3O2S/c1-19(2)9-5-3-4-8-16-30-25(32)22-10-6-7-11-23(22)29-26(30)33-18-24(31)28-17-20-12-14-21(27)15-13-20/h6-7,10-15,19H,3-5,8-9,16-18H2,1-2H3,(H,28,31)
C26H32ClN3O2S486.0691811700
20330255

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C26H32ClN3O2S/c1-17-13-18(2)16-30(15-17)12-4-11-28-26(31)24-25(33-21-8-5-19(27)6-9-21)22-10-7-20(32-3)14-23(22)29-24/h5-10,14,17-18,29H,4,11-13,15-16H2,1-3H3,(H,28,31)
C26H32ClN3O2S486.06929800
20330256
InChI=1/C26H32ClN3O2S/c1-30(19-7-4-3-5-8-19)16-6-15-28-26(31)24-25(33-21-12-9-18(27)10-13-21)22-14-11-20(32-2)17-23(22)29-24/h9-14,17,19,29H,3-8,15-16H2,1-2H3,(H,28,31)
C26H32ClN3O2S486.06929700
20330257

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C26H32ClN3O2S/c1-17-6-4-7-18(2)30(17)15-5-14-28-26(31)24-25(33-21-11-8-19(27)9-12-21)22-13-10-20(32-3)16-23(22)29-24/h8-13,16-18,29H,4-7,14-15H2,1-3H3,(H,28,31)
C26H32ClN3O2S486.06929800
22951222

Double-bond stereo
InChI=1/C26H32ClN3O2S/c1-3-5-15-29(4-2)16-9-14-28-25(31)19-30-22-12-6-7-13-23(22)33-24(26(30)32)18-20-10-8-11-21(27)17-20/h6-8,10-13,17-18H,3-5,9,14-16,19H2,1-2H3,(H,28,31)/b24-18+
C26H32ClN3O2S486.06928600
23017689

Double-bond stereo
InChI=1/C26H32ClN3O2S/c1-3-14-29(15-4-2)16-8-13-28-25(31)19-30-22-11-5-6-12-23(22)33-24(26(30)32)18-20-9-7-10-21(27)17-20/h5-7,9-12,17-18H,3-4,8,13-16,19H2,1-2H3,(H,28,31)/b24-18-
C26H32ClN3O2S486.06928700
23018577

Double-bond stereo
InChI=1/C26H32ClN3O2S/c1-3-5-13-30(14-6-4-2)15-12-28-25(31)20-10-11-23-22(18-20)29-26(32)24(33-23)17-19-8-7-9-21(27)16-19/h7-11,16-18H,3-6,12-15H2,1-2H3,(H,28,31)(H,29,32)/b24-17+
C26H32ClN3O2S486.06928700
23018589

Double-bond stereo
InChI=1/C26H32ClN3O2S/c1-3-5-14-30(13-4-2)15-7-12-28-25(31)20-10-11-23-22(18-20)29-26(32)24(33-23)17-19-8-6-9-21(27)16-19/h6,8-11,16-18H,3-5,7,12-15H2,1-2H3,(H,28,31)(H,29,32)/b24-17+
C26H32ClN3O2S486.06928700
23018640

Double-bond stereo
InChI=1/C26H32ClN3O2S/c1-3-5-14-30(15-6-4-2)16-13-28-25(31)20-11-12-23-22(17-20)29-26(32)24(33-23)18-19-9-7-8-10-21(19)27/h7-12,17-18H,3-6,13-16H2,1-2H3,(H,28,31)(H,29,32)/b24-18+
C26H32ClN3O2S486.06928700
22192485

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H32ClN3O2S/c1-33-23-7-5-20(6-8-23)18-26(11-9-24(31)28-26)12-10-25(32)30-15-13-29(14-16-30)19-21-3-2-4-22(27)17-21/h2-8,17H,9-16,18-19H2,1H3,(H,28,31)
C26H32ClN3O2S486.06927600
2532098

Double-bond stereo

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H32ClN3O2S/c1-4-5-6-7-8-15-30-24(31)17-23(25(32)29-22-14-9-18(2)16-19(22)3)33-26(30)28-21-12-10-20(27)11-13-21/h9-14,16,23H,4-8,15,17H2,1-3H3,(H,29,32)/b28-26-
C26H32ClN3O2S486.06925200
2823781

Double-bond stereo

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H32ClN3O2S/c1-2-3-4-5-9-18-30-24(31)19-23(25(32)28-17-16-20-10-7-6-8-11-20)33-26(30)29-22-14-12-21(27)13-15-22/h6-8,10-15,23H,2-5,9,16-19H2,1H3,(H,28,32)/b29-26-
C26H32ClN3O2S486.069185200
3262924

Double-bond stereo

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H32ClN3O2S/c1-2-3-4-5-9-17-30-24(31)19-23(25(32)28-16-15-20-11-7-6-8-12-20)33-26(30)29-22-14-10-13-21(27)18-22/h6-8,10-14,18,23H,2-5,9,15-17,19H2,1H3,(H,28,32)/b29-26-
C26H32ClN3O2S486.06925200
3368935

Double-bond stereo

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H32ClN3O2S/c1-4-5-6-7-8-14-30-24(31)17-23(25(32)29-22-13-12-18(2)15-19(22)3)33-26(30)28-21-11-9-10-20(27)16-21/h9-13,15-16,23H,4-8,14,17H2,1-3H3,(H,29,32)/b28-26-
C26H32ClN3O2S486.069185200
3630819

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H32ClN3O2S/c1-2-3-4-5-9-17-29-23(19-24(31)28-22-14-12-21(27)13-15-22)25(32)30(26(29)33)18-16-20-10-7-6-8-11-20/h6-8,10-15,23H,2-5,9,16-19H2,1H3,(H,28,31)
C26H32ClN3O2S486.069185200
84430236

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H31N3O2S.ClH/c30-26(27-18-23(25-10-7-15-32-25)29-13-5-1-2-6-14-29)22-17-24(31-28-22)21-12-11-19-8-3-4-9-20(19)16-21;/h7,10-12,15-17,23H,1-6,8-9,13-14,18H2,(H,27,30);1H
C26H32ClN3O2S486.06924300
84430239

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H31N3O2S.ClH/c1-18-10-12-29(13-11-18)23(25-7-4-14-32-25)17-27-26(30)22-16-24(31-28-22)21-9-8-19-5-2-3-6-20(19)15-21;/h4,7-9,14-16,18,23H,2-3,5-6,10-13,17H2,1H3,(H,27,30);1H
C26H32ClN3O2S486.06924300
3052132
InChI=1/C26H32ClN3O2S/c1-18-21(25(31)28-13-8-14-32-2)15-24(30(18)16-19-9-4-3-5-10-19)23-17-33-26(29-23)20-11-6-7-12-22(20)27/h6-7,11-12,15,17,19H,3-5,8-10,13-14,16H2,1-2H3,(H,28,31)
C26H32ClN3O2S486.069184300
3086454
InChI=1/C26H32ClN3O2S/c1-18-21(25(31)28-16-19-9-4-3-5-10-19)15-24(30(18)13-8-14-32-2)23-17-33-26(29-23)20-11-6-7-12-22(20)27/h6-7,11-12,15,17,19H,3-5,8-10,13-14,16H2,1-2H3,(H,28,31)
C26H32ClN3O2S486.06924300
33371808

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H32ClN3O2S/c27-22-11-5-4-10-21(22)25(32)29-23(20-8-2-1-3-9-20)18-24(31)28-19-26(12-6-7-13-26)30-14-16-33-17-15-30/h1-5,8-11,23H,6-7,12-19H2,(H,28,31)(H,29,32)
C26H32ClN3O2S486.06923300
12345

Advertisement